Zachary Bliek, DPM
Podiatrist · Des Moines, IANPI 1982229845
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (48.2%), travel and lodging and education — rather than concentrated in one kind of arrangement. 17 manufacturers reported payments, led by Stryker at 52.3% of the total. Reporting peaked in 2022 at $3,542 and has fallen 78.4% since, to $764 in 2025.
Across 99 payments — averaging $76.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$4K
- Medical Device Business Services, Inc.$2K
- Johnson & Johnson$428
- Arthrex$288
- Ossio Inc$273
- Prism Medical$251
- plus $703 from 11 others
What the payments were for
- Travel & lodging$3,23443%
- Food & beverage$3,63148%
- Education$6679%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 36 | $3,941 |
| Medical Device Business Services, Inc. | 8 | $1,649 |
| Johnson & Johnson | 14 | $428 |
| Arthrex | 3 | $288 |
| Ossio Inc | 2 | $273 |
| Prism Medical | 6 | $251 |
| Lilly USA, LLC | 8 | $132 |
| Pfizer | 5 | $109 |
| Boehringer Ingelheim | 5 | $107 |
| Medline Industries LP | 2 | $98 |
| Orthofix Medical, Inc. | 2 | $68 |
| Merck | 3 | $55 |
| Integra Lifesciences Corporation | 1 | $43 |
| Zimmer Biomet | 1 | $38 |
| Cranial Technologies, Inc | 1 | $26 |
| Biogennix, LLC | 1 | $14 |
| Radius Health, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PROstep$1,155
- INBONE$871
- INVISION$871
- PROPHECY$871
- ORTHOLOC 2 LAPIFUSE$316
- ORTHOLOC 3DI CROSSCHECK$170
- Viaflow$170
- HOFFMANN$162
- ORTHOLOC 3DI$133
- MOTOBAND$131
- ACTISHIELD CF$106
How this compares
$7,533 in reported general payments places this provider in the 85th percentile of 94 podiatrist providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 15 | $173 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 17 | $124 |
| Methylprednisolone | 22 | $104 |
| Meloxicam | 19 | $38 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Des Moines
- Kelly JohnDes Moines$8K
- Donald GodfreeDes Moines$7K
- Katrina AlmeidaDes Moines$4K
- Scot FreschiDes Moines$3K
- Allen KempfDes Moines$3K
- Mathew JohnstoneDes Moines$2K
- Ashley DikisDes Moines$2K
- John BennettDes Moines$1K
- Ashley BerryDes Moines$686
- Paul DaytonAnkeny$9.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.